Bhutan vs Lower-middle income (World Bank): Pneumococcal conjugate second or third-dose vaccines (PCVc)
Bhutan
99.0%
in 2025
Lower-middle income (World Bank)
81.0%
in 2025
Bhutan rank
1st
Lower-middle income (World Bank) rank
4th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Bhutan
- Lower-middle income (World Bank)
How they compare
Bhutan currently reports 99.0% against 81.0% in Lower-middle income (World Bank), a difference of 18.0%.
That makes Bhutan's figure about 1.2 times Lower-middle income (World Bank)'s.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was Lower-middle income (World Bank) ahead.
Bhutan ranks 1st and Lower-middle income (World Bank) ranks 4th of 194 countries.
Across the 3 decades both report, Bhutan averaged higher in 1 and Lower-middle income (World Bank) in 1.
Head to head by decade
| Decade | Bhutan | Lower-middle income (World Bank) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 2.6% | 24.9% | 22.3% | Lower-middle income (World Bank) |
| 2020s | 96.3% | 68.0% | 28.3% | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Bhutan or Lower-middle income (World Bank)?
- Bhutan, at 99.0% against 81.0% in Lower-middle income (World Bank) as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Bhutan and Lower-middle income (World Bank)?
- 18.0%, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Lower-middle income (World Bank)?
- 18 years are reported by both, from 2008 to 2025.
- How do Bhutan and Lower-middle income (World Bank) rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Bhutan ranks 1st and Lower-middle income (World Bank) ranks 4th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.